P. Zabel

5.7k total citations
116 papers, 4.0k citations indexed

About

P. Zabel is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, P. Zabel has authored 116 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Pulmonary and Respiratory Medicine, 23 papers in Epidemiology and 21 papers in Physiology. Recurrent topics in P. Zabel's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Immune Response and Inflammation (14 papers) and Neonatal Respiratory Health Research (12 papers). P. Zabel is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (15 papers), Immune Response and Inflammation (14 papers) and Neonatal Respiratory Health Research (12 papers). P. Zabel collaborates with scholars based in Germany, United States and United Kingdom. P. Zabel's co-authors include Max Schlaak, Klaus Dalhoff, Torsten Goldmann, P. Entzian, Ekkehard Vollmer, Daniel Droemann, D. Branscheid, Bernhard Schaaf, Joachim Müller‐Quernheim and K Linnemann and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

P. Zabel

111 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Zabel Germany 32 1.4k 1.0k 927 777 692 116 4.0k
Simone Rosseau Germany 37 1.4k 1.0× 1.4k 1.3× 621 0.7× 1.2k 1.5× 1.2k 1.7× 94 5.0k
Yves Sibille Belgium 29 1.6k 1.2× 965 0.9× 773 0.8× 596 0.8× 603 0.9× 79 3.7k
Urszula Demkow Poland 34 735 0.5× 1.4k 1.4× 794 0.9× 795 1.0× 1.0k 1.5× 305 4.6k
Martin R. Stämpfli Canada 42 1.8k 1.3× 1.9k 1.9× 1.8k 1.9× 737 0.9× 1.2k 1.7× 135 5.5k
Thomas Tschernig Germany 45 1.5k 1.1× 2.0k 1.9× 1.1k 1.2× 791 1.0× 1.4k 2.1× 286 6.3k
Jeffrey D. Hasday United States 50 1.9k 1.4× 1.7k 1.6× 1.5k 1.6× 909 1.2× 1.8k 2.6× 140 6.6k
Ling‐Pei Ho United Kingdom 32 1.1k 0.8× 1.1k 1.0× 984 1.1× 573 0.7× 675 1.0× 74 3.5k
Arturo González‐Quintela Spain 39 507 0.4× 664 0.6× 1.1k 1.2× 1.1k 1.4× 586 0.8× 203 5.0k
Michael D. Roth United States 51 2.1k 1.6× 2.2k 2.1× 647 0.7× 1.1k 1.4× 921 1.3× 125 6.9k
Stewart J. Levine United States 41 808 0.6× 1.4k 1.4× 911 1.0× 633 0.8× 1.3k 1.9× 107 4.7k

Countries citing papers authored by P. Zabel

Since Specialization
Citations

This map shows the geographic impact of P. Zabel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Zabel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Zabel more than expected).

Fields of papers citing papers by P. Zabel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Zabel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Zabel. The network helps show where P. Zabel may publish in the future.

Co-authorship network of co-authors of P. Zabel

This figure shows the co-authorship network connecting the top 25 collaborators of P. Zabel. A scholar is included among the top collaborators of P. Zabel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Zabel. P. Zabel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zabel, P., et al.. (2011). Nutzen und Sicherheit der Behandlung von Pleuraergüssen mit dem PleurX-Katheter: eine retrospektive Analyse. Pneumologie. 65(9). 558–564. 1 indexed citations
2.
Schultz, Holger, D. Branscheid, Klaus Dalhoff, et al.. (2009). Expression of the acute phase protein haptoglobin in human lung cancer and tumor-free lung tissues. Pathology - Research and Practice. 205(9). 639–647. 41 indexed citations
3.
Hauber, Hans‐Peter, et al.. (2008). Inhalation with Fucose and Galactose for Treatment of Pseudomonas Aeruginosa in Cystic Fibrosis Patients. International Journal of Medical Sciences. 5(6). 371–376. 79 indexed citations
4.
Schultz, Holger, et al.. (2008). TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens. Diagnostic Pathology. 3(1). 35–35. 40 indexed citations
5.
Droemann, Daniel, Jan Rupp, Torsten Goldmann, et al.. (2007). Disparate Innate Immune Responses to Persistent and Acute Chlamydia pneumoniae Infection in Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine. 175(8). 791–797. 27 indexed citations
6.
Pletz, Mathias W., Heiko Golpon, Torsten Bauer, et al.. (2006). Pharmakotherapie bei Schwerem Akutem Respiratorischem Syndrom (SARS). Pneumologie. 60(11). 694–700. 1 indexed citations
7.
Groneberg, David A., R. Hilgenfeld, & P. Zabel. (2005). Molecular mechanisms of severe acute respiratory syndrome (SARS). Respiratory Research. 6(1). 8–8. 71 indexed citations
8.
Uhlig, Ulrike, Stefan Uhlig, D. Branscheid, et al.. (2004). HOPE technique enables western blot analysis from paraffin-embedded tissues. Pathology - Research and Practice. 200(6). 469–472. 18 indexed citations
9.
Schaaf, Bernhard, Hamed Esnaashari, Ulrike Seitzer, et al.. (2003). Pneumococcal Septic Shock Is Associated with the Interleukin-10–1082 Gene Promoter Polymorphism. American Journal of Respiratory and Critical Care Medicine. 168(4). 476–480. 141 indexed citations
10.
Groneberg, David A., et al.. (2003). Severe acute respiratory syndrome: global initiatives for disease diagnosis. QJM. 96(11). 845–852. 36 indexed citations
11.
Lepp, Ute, P. Zabel, & Frauke Schocker. (2002). Playing cards as a carrier for peanut allergens. Allergy. 57(9). 864–864. 7 indexed citations
12.
Schaaf, Bernhard, Ulrike Seitzer, Vera Pravica, Sven Philip Aries, & P. Zabel. (2001). Tumor Necrosis Factor- α − 308 Promoter Gene Polymorphism and Increased Tumor Necrosis Factor Serum Bioactivity in Farmer's Lung Patients. American Journal of Respiratory and Critical Care Medicine. 163(2). 379–382. 61 indexed citations
13.
Schröder, J, et al.. (1998). [Pentoxifylline as adjuvant therapy of multiple organ failure].. PubMed. 115(Suppl I). 461–5. 1 indexed citations
14.
Ziegenhagen, Manfred W., P. Zabel, Gernot Zissel, Max Schlaak, & Joachim Müller‐Quernheim. (1998). Serum Level of Interleukin 8 Is Elevated in Idiopathic Pulmonary Fibrosis and Indicates Disease Activity. American Journal of Respiratory and Critical Care Medicine. 157(3). 762–768. 112 indexed citations
15.
Ziegenhagen, Manfred W., et al.. (1997). Sarcoidosis: TNF- α Release from Alveolar Macrophages and Serum Level of sIL-2R Are Prognostic Markers. American Journal of Respiratory and Critical Care Medicine. 156(5). 1586–1592. 187 indexed citations
16.
Zabel, P., P. Entzian, Klaus Dalhoff, & Max Schlaak. (1997). Pentoxifylline in Treatment of Sarcoidosis. American Journal of Respiratory and Critical Care Medicine. 155(5). 1665–1669. 149 indexed citations
17.
Seitzer, Ulrike, Cezary Swider, Frank Stüber, et al.. (1997). TUMOUR NECROSIS FACTOR ALPHA PROMOTER GENE POLYMORPHISM IN SARCOIDOSIS. Cytokine. 9(10). 787–790. 109 indexed citations
18.
Entzian, P., Max Schlaak, Ulrike Seitzer, et al.. (1997). Antiinflammatory and Antifibrotic Properties of Colchicine: Implications for Idiopathic Pulmonary Fibrosis. Lung. 175(1). 41–51. 59 indexed citations
19.
Entzian, P., K Linnemann, Max Schlaak, & P. Zabel. (1996). Obstructive Sleep Apnea Syndrome and Circadian Rhythms of Hormones and Cytokines. American Journal of Respiratory and Critical Care Medicine. 153(3). 1080–1086. 202 indexed citations
20.
Leimenstoll, G., et al.. (1994). Effect of renal function on cytokine secretion of monocytes and lymphocytes. Nephrology Dialysis Transplantation. 9(5). 493–498. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Simone Rosseau Breakdown of academic impact, for papers by Yves Sibille Breakdown of academic impact, for papers by Urszula Demkow Breakdown of academic impact, for papers by Martin R. Stämpfli Breakdown of academic impact, for papers by Thomas Tschernig Breakdown of academic impact, for papers by Jeffrey D. Hasday Breakdown of academic impact, for papers by Ling‐Pei Ho Breakdown of academic impact, for papers by Arturo González‐Quintela Breakdown of academic impact, for papers by Michael D. Roth Breakdown of academic impact, for papers by Stewart J. Levine
Rankless by CCL
2026